Join to access to all OVN content. Join for Free
Illuminating science for patients and healthcare professionals through plain language podcasts
patient engagement in podcasts medical education podcasts MedComms webinars scientific communication for patients expert-led

Illuminating science for patients and healthcare professionals through plain language podcasts


Share This Article


Summary

Note this is a video recording of an online meeting conducted using the Zoom.us platform. Inevitably such recordings suffer a little in terms of their production values because of the internet connectivity and quality of webcams. Despite that, they allow us to provide additional valuable insights in to the MedComms business and we can involve a wider range of speakers who can participate from the comfort of their own desks, wherever in the world they are.

Expert-led podcasts summarising the latest clinical data and expert opinion, including discussions of data presented at scientific congresses, have been published by journals as peer-reviewed, citable publications. They have also been published as part of IME (independent medical education) programmes. But is it possible to create these podcasts in plain language, with both patient and healthcare professional authors? If we are trying to educate a broad audience of stakeholders (from lay audiences to highly specialised clinicians) with scientific content, can patients be podcast authors and create content with maximum impact? The answer to these key questions is yes!

Join Caroline Halford from Springer Healthcare, Niamh Clarke from Adis, and Catherine Elliott and Simon Stones from Envision Pharma Group to hear about their experience of creating plain language podcasts and the potential for using these types of initiative to make scientific information more impactful, and more accessible to a wider audience.

And we answer questions from the audience.

It should be of interest to anyone who is working in and around MedComms, publications, medical education, or has an interest in patient engagement.

Recorded 09 November 2022 as a MedComms Networking webinar. Produced by NetworkPharma.tv

Find out more about Springer Healthcare and Adis journals at https://springerhealthcare.com/

Find out more about Envision Pharma Group at https://www.envisionpharmagroup.com/

Further information:

Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast
See https://link.springer.com/article/10.1007/s40487-022-00185-5

CME patient podcasts from Springer Healthcare IME,
See https://fop.ime.springerhealthcare.com/insights/#podcasts

Click for Source
patient engagement in podcasts, medical education podcasts, MedComms webinars, scientific communication for patients, expert-led

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
OVN Avatar J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Article
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
OVN Avatar Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Explore OVN